Skip to content
RDL Network logo
Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia — Kenneth Onimus (2022) | RDL Network